Cullen/Frost Bankers’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Cullen/Frost Bankers’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-25	Closed	-$5K	–	1249
2021 Q1	$5K	Hold	25	–	–	﹤0.01%	989
2020 Q4	$3K	Hold	25	–	–	﹤0.01%	996
2020 Q3	$2K	Hold	25	–	–	﹤0.01%	1053
2020 Q2	$3K	Hold	25	–	–	﹤0.01%	1014
2020 Q1	$2K	Hold	25	–	–	﹤0.01%	870
2019 Q4	$3K	Hold	25	–	–	﹤0.01%	985
2019 Q3	$3K	Hold	25	–	–	﹤0.01%	960
2019 Q2	$4K	Hold	25	–	–	﹤0.01%	942
2019 Q1	$4K	Buy	+25	New	+$3.72K	﹤0.01%	824

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $983M AUM 34.23% 1-Year Est. Return

Cullen/Frost Bankers's GWPH Position: Q2 2021 in Review

Cullen/Frost Bankers sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 25 shares — an estimated $5K sold.

Cullen/Frost Bankers first reported a position in GWPH in Q1 2019 and held it in 9 quarters. The position peaked at $5K in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Cullen/Frost Bankers reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Cullen/Frost Bankers sold 25 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $5K.
Cullen/Frost Bankers first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2019 and held it in 9 quarters.
Cullen/Frost Bankers's GW Pharmaceuticals Plc American Depositary Shares position peaked at $5K in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Cullen/Frost Bankers's 13F filing for Q2 2021, filed 5 Aug 2021.